JP2014516968A5 - - Google Patents

Download PDF

Info

Publication number
JP2014516968A5
JP2014516968A5 JP2014511589A JP2014511589A JP2014516968A5 JP 2014516968 A5 JP2014516968 A5 JP 2014516968A5 JP 2014511589 A JP2014511589 A JP 2014511589A JP 2014511589 A JP2014511589 A JP 2014511589A JP 2014516968 A5 JP2014516968 A5 JP 2014516968A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
salt
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014516968A (ja
JP5951757B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/038615 external-priority patent/WO2012159047A1/en
Publication of JP2014516968A publication Critical patent/JP2014516968A/ja
Publication of JP2014516968A5 publication Critical patent/JP2014516968A5/ja
Application granted granted Critical
Publication of JP5951757B2 publication Critical patent/JP5951757B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511589A 2011-05-19 2012-05-18 抗hiv剤を調製するためのプロセスおよび中間体 Active JP5951757B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161488133P 2011-05-19 2011-05-19
US61/488,133 2011-05-19
PCT/US2012/038615 WO2012159047A1 (en) 2011-05-19 2012-05-18 Processes and intermediates for preparing anti-hiv agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016005955A Division JP6282295B2 (ja) 2011-05-19 2016-01-15 抗hiv剤を調製するためのプロセスおよび中間体

Publications (3)

Publication Number Publication Date
JP2014516968A JP2014516968A (ja) 2014-07-17
JP2014516968A5 true JP2014516968A5 (enExample) 2015-07-02
JP5951757B2 JP5951757B2 (ja) 2016-07-13

Family

ID=46208163

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014511589A Active JP5951757B2 (ja) 2011-05-19 2012-05-18 抗hiv剤を調製するためのプロセスおよび中間体
JP2016005955A Active JP6282295B2 (ja) 2011-05-19 2016-01-15 抗hiv剤を調製するためのプロセスおよび中間体
JP2017019959A Active JP6621772B2 (ja) 2011-05-19 2017-02-06 抗hiv剤を調製するためのプロセスおよび中間体
JP2019017324A Pending JP2019089808A (ja) 2011-05-19 2019-02-01 抗hiv剤を調製するためのプロセスおよび中間体

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016005955A Active JP6282295B2 (ja) 2011-05-19 2016-01-15 抗hiv剤を調製するためのプロセスおよび中間体
JP2017019959A Active JP6621772B2 (ja) 2011-05-19 2017-02-06 抗hiv剤を調製するためのプロセスおよび中間体
JP2019017324A Pending JP2019089808A (ja) 2011-05-19 2019-02-01 抗hiv剤を調製するためのプロセスおよび中間体

Country Status (10)

Country Link
US (5) US8987437B2 (enExample)
EP (3) EP3199537B1 (enExample)
JP (4) JP5951757B2 (enExample)
AR (1) AR086492A1 (enExample)
AU (4) AU2012255029B2 (enExample)
CA (1) CA2835932C (enExample)
ES (2) ES2629913T3 (enExample)
PT (2) PT3199537T (enExample)
TW (1) TWI635093B (enExample)
WO (1) WO2012159047A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR086492A1 (es) 2011-05-19 2013-12-18 Gilead Sciences Inc Procedimientos e intermediarios para preparar agentes anti-hiv
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
EP3518935A1 (en) 2016-09-27 2019-08-07 Gilead Sciences, Inc. Therapeutic compositions for treatment of human immunodeficiency virus
ES2969496T3 (es) 2017-08-01 2024-05-20 Gilead Sciences Inc Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2- il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
KR102526964B1 (ko) 2018-02-26 2023-04-28 길리애드 사이언시즈, 인코포레이티드 Hbv 복제 억제제로서의 치환된 피롤리진 화합물
CN112175003B (zh) * 2019-07-01 2022-02-15 上海医药工业研究院 一种苯基氢膦酸酯及其中间体的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US599431A (en) 1898-02-22 Clothes-wringer
GB835785A (en) * 1956-04-30 1960-05-25 Victor Chemical Works Method of making diaryl phosphites
MX3898E (es) * 1975-12-29 1981-09-10 Monsanto Co Procedimiento mejorado para la preparacion de triesteres de n-fosfonometilglicina
US4198355A (en) * 1977-03-28 1980-04-15 Mobil Oil Corporation Preparation of tertiary alkylphosphorodichloridite derivatives
US5459256A (en) * 1987-04-17 1995-10-17 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Lipophilic, aminohydrolase-activated prodrugs
HU906976D0 (en) 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
MXPA03000587A (es) 2000-07-21 2004-04-05 Gilead Sciences Inc Profarmacos de analogos de nucleotido de fosfonato y metodos para seleccionar y elaborar los mismos.
NZ535828A (en) * 2002-04-26 2007-10-26 Gilead Sciences Inc Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
DK1628685T3 (da) * 2003-04-25 2011-03-21 Gilead Sciences Inc Antivirale phosphonatanaloge
JP2010535701A (ja) * 2003-04-25 2010-11-25 ギリアード サイエンシーズ, インコーポレイテッド 抗癌ホスホネートアナログ
MX2007000584A (es) * 2004-07-16 2007-06-25 Gilead Sciences Inc Compuestos antivirales.
AU2005330489B2 (en) 2004-07-27 2011-08-25 Gilead Sciences, Inc. Nucleoside phosphonate conjugates as anti HIV agents
EP1906971A2 (en) * 2005-07-27 2008-04-09 Gilead Sciences, Inc. Antiviral compounds
MX2008011640A (es) * 2006-03-17 2008-09-22 Invista Tech Sarl Metodo para la purificacion de triorganofosfitos por tratamiento con un aditivo basico.
US8324179B2 (en) * 2007-02-09 2012-12-04 Gilead Sciences, Inc. Nucleoside analogs for antiviral treatment
PE20110219A1 (es) * 2008-07-08 2011-03-31 Gilead Sciences Inc Sales del compuesto n-[(s)({[(2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il]oxi}metil)fenoxifosfinoil]-l-alaninato de etilo como inhibidores de vih
WO2011003018A2 (en) * 2009-07-01 2011-01-06 Cornell University Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof
AR086492A1 (es) 2011-05-19 2013-12-18 Gilead Sciences Inc Procedimientos e intermediarios para preparar agentes anti-hiv

Similar Documents

Publication Publication Date Title
JP2014516968A5 (enExample)
JP2018529687A5 (enExample)
KR101532570B1 (ko) 벤즈아미드 화합물의 합성에 유용한 화합물
JP2021506774A (ja) 抗蠕虫性4−アミノ−キノリン−3−カルボキサミド誘導体を調製する方法
KR20130142477A (ko) 키랄 나이트로사이클로프로판 유도체의 제조방법
PE20231843A1 (es) Reactivos quirales para la preparacion de oligomeros homogeneos
CA3037554A1 (en) Process for the preparation of (1r,3r)- and (1s,3s)-2,2-dihalo-3-(substituted phenyl)cyclopropanecarboxylic acids
CN1839120A (zh) 顺-4-氟-l-脯氨酸衍生物的制备方法
TWI455933B (zh) 貝他斯汀或其苯磺酸鹽之製法及其使用之中間體
CN104086509A (zh) 甲基丙烯酸缩水甘油酯的合成方法
RU2018100967A (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
JP2015500875A (ja) マグノロール類似体を製造するための方法
JP2016537447A5 (enExample)
AR054849A1 (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
JP6228210B2 (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法
EP2522648B1 (en) Process for producing difluorocyclopropane compound
JP2017095455A (ja) N,n’−ビス(2−シアノエチル)−1,2−エチレンジアミンの調製方法
JP2018505179A5 (enExample)
EP2888250B1 (en) Process for the synthesis of substituted gamma lactams
KR101462468B1 (ko) 염산 에페리손의 제조방법
RU2016113336A (ru) Производные оксимов 4-бензоилпиридина, обладающие противосудорожной активностью, как средства лечения эпилепсии и пароксизмальных состояний
KR101468209B1 (ko) 4차 탄소를 갖는 아민 유도체 및 이의 제조방법
JP2014024755A (ja) α−フルオロアクリル酸エステルの製造方法
JP2014525897A5 (enExample)
JP6649368B2 (ja) カンプトテシン類似体合成のための方法およびシステム